drugset / Trial / NCT03780959
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective of this study was to determine the efficacy of etanercept in children with polyarticular course JRA.
Timeline
- Start
- 1997-05-01
- Primary completion
- 1998-07-08
- Completion
- 1998-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 0.4 mg/kg | Subcutaneous |